Delivery Order SPE2DB22D3501-SPE2DB25FWP45
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates...
- This is a $3,294.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ANNOVERA vaginal rings. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen is an experienced federal contractor, holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,304.84, is for the supply of the vaginal contraceptive ring product Annovera. The contract is a firm-fixed-price delivery order with a performance period through May 13, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ANNOVERA vaginal rings. The contract, valued at $3,966.60, is a firm fixed price delivery order with a completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,348.82 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ANNOVERA vaginal rings. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to deliver pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Annovera vaginal rings. The $2,050.77 contract has a performance period through March 20, 2024. Amerisourcebergen is an experienced prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceutical products and medical...
- The U.S. government has awarded a $1,253.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of ANNOVERA vaginal rings. This contract is not set aside and is funded by the Defense Logistics Agency (DLA), which is a defense agency. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle...
- This is a $1,619.35 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of ANNOVERA vaginal rings, with a period of performance through July 14, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare...
- This is a $8,082.34 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ANNOVERA vaginal rings. The contract has an ultimate completion date of June 27, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of ANNOVERA vaginal rings. The contract has a ceiling value of $4,171.40 and a completion date of July 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this contract, which is a firm fixed-price delivery order with no set-aside designation. This contract is part of a larger Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP45Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. Through this delivery order mechanism, the company continues to fulfill specialized pharmaceutical needs for the federal healthcare supply chain under the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/25/25 |